Tools & Wizards About Us
pptaglobal.org screenshot

Report Summary

  • 16

    Performance

    Renders faster than
    30% of other websites

  • 97

    Accessibility

    Visual factors better than
    that of 91% of websites

  • 83

    Best Practices

    More advanced features
    available than in
    55% of websites

  • 90

    SEO

    Google-friendlier than
    68% of websites

pptaglobal.org

Home - Plasma Protein Therapeutics Association

Page Load Speed

9.3 sec in total

First Response

99 ms

Resources Loaded

6.6 sec

Page Rendered

2.6 sec

pptaglobal.org screenshot

About Website

Click here to check amazing Pptaglobal content for United States. Otherwise, check out these important facts you probably never knew about pptaglobal.org

The Plasma Protein Therapeutics Association (PPTA) represents the manufacturers of plasma-derived and recombinant analog therapies.

Visit pptaglobal.org

Key Findings

We analyzed Pptaglobal.org page load time and found that the first response time was 99 ms and then it took 9.2 sec to load all DOM resources and completely render a web page. This is a poor result, as 85% of websites can load faster.

Performance Metrics

pptaglobal.org performance score

16

Measured Metrics

name

value

score

weighting

FCP (First Contentful Paint)

Value6.3 s

3/100

10%

LCP (Largest Contentful Paint)

Value9.1 s

1/100

25%

SI (Speed Index)

Value14.0 s

1/100

10%

TBT (Total Blocking Time)

Value7,240 ms

0/100

30%

CLS (Cumulative Layout Shift)

Value0

100/100

15%

TTI (Time to Interactive)

Value40.0 s

0/100

10%

Network Requests Diagram

pptaglobal.org

99 ms

pptaglobal.org

42 ms

www.pptaglobal.org

5197 ms

ppta1.364506bdd.min.css

60 ms

mirrorclick.js

41 ms

Our browser made a total of 247 requests to load all elements on the main page. We found that 1% of them (3 requests) were addressed to the original Pptaglobal.org, 86% (212 requests) were made to Cdn.prod.website-files.com and 3% (7 requests) were made to Cdn.jsdelivr.net. The less responsive or slowest element that took the longest time to load (5.2 sec) belongs to the original domain Pptaglobal.org.

Page Optimization Overview & Recommendations

Page size can be reduced by 10.1 MB (33%)

Content Size

30.7 MB

After Optimization

20.6 MB

  • HTML
  • Images
  • JavaScript
  • CSS

In fact, the total size of Pptaglobal.org main page is 30.7 MB. This result falls beyond the top 1M of websites and identifies a large and not optimized web page that may take ages to load. Only a small number of websites need less resources to load. Images take 29.7 MB which makes up the majority of the site volume.

HTML Optimization

-90%

Potential reduce by 452.6 kB

  • Original 505.4 kB
  • After minification 504.6 kB
  • After compression 52.7 kB

HTML content can be minified and compressed by a website’s server. The most efficient way is to compress content using GZIP which reduces data amount travelling through the network between server and browser. HTML code on this page is well minified. It is highly recommended that content of this web page should be compressed using GZIP, as it can save up to 452.6 kB or 90% of the original size.

Image Optimization

-33%

Potential reduce by 9.7 MB

  • Original 29.7 MB
  • After minification 20.1 MB

Image size optimization can help to speed up a website loading time. The chart above shows the difference between the size before and after optimization. Obviously, Pptaglobal needs image optimization as it can save up to 9.7 MB or 33% of the original volume. The most popular and efficient tools for JPEG and PNG image optimization are Jpegoptim and PNG Crush.

JavaScript Optimization

-1%

Potential reduce by 2.3 kB

  • Original 381.2 kB
  • After minification 381.2 kB
  • After compression 378.9 kB

It’s better to minify JavaScript in order to improve website performance. The diagram shows the current total size of all JavaScript files against the prospective JavaScript size after its minification and compression. This website has mostly compressed JavaScripts.

CSS Optimization

-0%

Potential reduce by 0 B

  • Original 104.0 kB
  • After minification 104.0 kB
  • After compression 104.0 kB

CSS files minification is very important to reduce a web page rendering time. The faster CSS files can load, the earlier a page can be rendered. Pptaglobal.org has all CSS files already compressed.

Requests Breakdown

Number of requests can be reduced by 21 (9%)

Requests Now

234

After Optimization

213

  • AJAX
  • Images
  • JavaScript
  • CSS

The browser has sent 234 CSS, Javascripts, AJAX and image requests in order to completely render the main page of Pptaglobal. We recommend that multiple CSS and JavaScript files should be merged into one by each type, as it can help reduce assets requests from 17 to 1 for JavaScripts and as a result speed up the page load time.

Network Requests Diagram

pptaglobal.org

pptaglobal.org

99 ms

pptaglobal.org

pptaglobal.org

42 ms

www.pptaglobal.org

www.pptaglobal.org

5197 ms

ppta1.364506bdd.min.css

ppta1.364506bdd.min.css

60 ms

mirrorclick.js

mirrorclick.js

41 ms

selectcustom.js

selectcustom.js

51 ms

splide-core.min.css

splide-core.min.css

50 ms

cmscombine.js

cmscombine.js

50 ms

cmsload.js

cmsload.js

49 ms

jquery-3.5.1.min.dc5e7f18c8.js

jquery-3.5.1.min.dc5e7f18c8.js

43 ms

ppta1.33d403b62.js

ppta1.33d403b62.js

51 ms

clipboard.min.js

clipboard.min.js

230 ms

split-type

split-type

119 ms

gsap.min.js

gsap.min.js

238 ms

ScrollTrigger.min.js

ScrollTrigger.min.js

336 ms

splide.min.js

splide.min.js

42 ms

splide-extension-grid.min.js

splide-extension-grid.min.js

45 ms

gtm.js

gtm.js

117 ms

98 ms

641779b47dad69853a0a1f7e_Logo.svg

641779b47dad69853a0a1f7e_Logo.svg

22 ms

63dc1fa6f62b3758db0d14e7_logo-mobile.svg

63dc1fa6f62b3758db0d14e7_logo-mobile.svg

26 ms

6392182566f0ecded8117664_search-icon.svg

6392182566f0ecded8117664_search-icon.svg

26 ms

6392185adc0f3c65e64894f0_hamburguer-icon.svg

6392185adc0f3c65e64894f0_hamburguer-icon.svg

29 ms

63f52bd70988104eae5b78c1_Group%202218.svg

63f52bd70988104eae5b78c1_Group%202218.svg

30 ms

641aefdda258261e7b32f8b5_arrow.webp

641aefdda258261e7b32f8b5_arrow.webp

31 ms

641aeec02c4d6e6fb78fe8eb_arrow.png

641aeec02c4d6e6fb78fe8eb_arrow.png

120 ms

6410b10a950cc365617bbe3e_WYSDO-image1.webp

6410b10a950cc365617bbe3e_WYSDO-image1.webp

34 ms

6410b10accd1ca90b8f43180_WYSDO-image2.webp

6410b10accd1ca90b8f43180_WYSDO-image2.webp

52 ms

6410b101ded6126053d55b22_WYSDO-image3.webp

6410b101ded6126053d55b22_WYSDO-image3.webp

53 ms

63b46a9d20e1081bbec84947_93829119a49c7243b195de1fa9b6132e-min%20Grande.webp

63b46a9d20e1081bbec84947_93829119a49c7243b195de1fa9b6132e-min%20Grande.webp

55 ms

63bf15e89548d1acc81292fc_Cell7.webp

63bf15e89548d1acc81292fc_Cell7.webp

52 ms

64e7588f773afe2a4932fbea_Screenshot%202023-08-24%20091614.png

64e7588f773afe2a4932fbea_Screenshot%202023-08-24%20091614.png

53 ms

64db76045f73d23d6ff750df_web%20screenshot.png

64db76045f73d23d6ff750df_web%20screenshot.png

88 ms

64b5408f33afd0a5dd965f5e_Oksana%20Picture.png

64b5408f33afd0a5dd965f5e_Oksana%20Picture.png

219 ms

64a545d8b804e40b4f0af342_Thomas%20Kreil%20Winner%20of%20the%20Hilfenhaus%20Award%202023.png

64a545d8b804e40b4f0af342_Thomas%20Kreil%20Winner%20of%20the%20Hilfenhaus%20Award%202023.png

80 ms

647f05b62a93102e40eec25c_PPTA%20intro%20screenshot.webp

647f05b62a93102e40eec25c_PPTA%20intro%20screenshot.webp

79 ms

645b9564278594981b52d370_Screenshot%202023-05-10%20090001.png

645b9564278594981b52d370_Screenshot%202023-05-10%20090001.png

361 ms

6450f7f7cf3b7158eb0588d9_PPTA%20New%20Website%20and%20Brand%20Launch-cover.webp

6450f7f7cf3b7158eb0588d9_PPTA%20New%20Website%20and%20Brand%20Launch-cover.webp

87 ms

647f05324397b3363eb4ea49_The%20Brussels%20Times%20Hosts%20Event%20at%20the%20European%20Parliament.webp

647f05324397b3363eb4ea49_The%20Brussels%20Times%20Hosts%20Event%20at%20the%20European%20Parliament.webp

85 ms

640b899c6276f0e3036518c3_45-Take%20a%20tour%20of%20a%20plasma%20donation%20center%20in%20Frankfurt%2C%20Germany.jpg

640b899c6276f0e3036518c3_45-Take%20a%20tour%20of%20a%20plasma%20donation%20center%20in%20Frankfurt%2C%20Germany.jpg

193 ms

640b897509bfca09a1567f00_42-The%20need%20for%20a%20policy%20change%20%E2%80%93%20Plasma%20donation.jpg

640b897509bfca09a1567f00_42-The%20need%20for%20a%20policy%20change%20%E2%80%93%20Plasma%20donation.jpg

192 ms

647f04efb707a7b0f98800c0_2022International%20Plasma%20Protein%20Congress%20(IPPC)-%20Day%20One.webp

647f04efb707a7b0f98800c0_2022International%20Plasma%20Protein%20Congress%20(IPPC)-%20Day%20One.webp

122 ms

640b8981260a9f2a834173da_43-2022International%20Plasma%20Protein%20Congress%20(IPPC)-%20Day%20One.jpg

640b8981260a9f2a834173da_43-2022International%20Plasma%20Protein%20Congress%20(IPPC)-%20Day%20One.jpg

192 ms

640b89684481e4408af94872_41-Differentiating%20Plasma%20from%20Blood.jpg

640b89684481e4408af94872_41-Differentiating%20Plasma%20from%20Blood.jpg

221 ms

640b8956d2fdcf4bb013df82_40-U.S.%20Roundtable%20on%20Immunoglobulin%20Use.jpg

640b8956d2fdcf4bb013df82_40-U.S.%20Roundtable%20on%20Immunoglobulin%20Use.jpg

223 ms

640b894be5569ec9555f96de_39-EU%20BTC%20revision%20%E2%80%93%20The%20socioeconomic%20benefits%20of%20plasma-derived%20medicines.jpg

640b894be5569ec9555f96de_39-EU%20BTC%20revision%20%E2%80%93%20The%20socioeconomic%20benefits%20of%20plasma-derived%20medicines.jpg

222 ms

647e1e7b8dbc842018220a53_Why%20is%20Donating%20Plasma%20Important_.webp

647e1e7b8dbc842018220a53_Why%20is%20Donating%20Plasma%20Important_.webp

355 ms

647f04dc256f7b6c6c70ed59_Strengthening%20the%20EU%20Blood%20Directive%20for%20patients%20who%20need%20plasma-derived%20medicines.webp

647f04dc256f7b6c6c70ed59_Strengthening%20the%20EU%20Blood%20Directive%20for%20patients%20who%20need%20plasma-derived%20medicines.webp

354 ms

640b891c2ea4ad175e9af277_36-Meet%20Amber%2C%20a%20Teacher%20and%20Dedicated%20Plasma%20Donor.jpg

640b891c2ea4ad175e9af277_36-Meet%20Amber%2C%20a%20Teacher%20and%20Dedicated%20Plasma%20Donor.jpg

355 ms

647e1e996fe326937807249a_Europe%20needs%20to%20collect%20more%20plasma%20%E2%80%93%20Improving%20patient%20access%20to%20plasma-derived%20medicines.webp

647e1e996fe326937807249a_Europe%20needs%20to%20collect%20more%20plasma%20%E2%80%93%20Improving%20patient%20access%20to%20plasma-derived%20medicines.webp

356 ms

640b8900f321abb883f46148_34-EU%20BTC%20revision%20%E2%80%93%20Facts%20about%20compensating%20plasma%20donors.jpg

640b8900f321abb883f46148_34-EU%20BTC%20revision%20%E2%80%93%20Facts%20about%20compensating%20plasma%20donors.jpg

405 ms

640b88c810f75fc58a0dfbd2_30-April%202021%20Online%20Roundtable%20hosted%20by%20MEP%20Sirpa%20Pietika%CC%88inen%20(EPP%2C%20Finland).jpg

640b88c810f75fc58a0dfbd2_30-April%202021%20Online%20Roundtable%20hosted%20by%20MEP%20Sirpa%20Pietika%CC%88inen%20(EPP%2C%20Finland).jpg

360 ms

647f047ccaaebba6e235b46b_Introduction%20to%20the%20Global%20Journey%20of%20Plasma%20webinar%20link.webp

647f047ccaaebba6e235b46b_Introduction%20to%20the%20Global%20Journey%20of%20Plasma%20webinar%20link.webp

357 ms

640b866d84373f63b85f8a7b_26-Highlights%20from%20the%20EP%20roundtable%20event%20%E2%80%9CEnsuring%20Appropriate%20Patient%20Access%20to%20PDMPs.jpg

640b866d84373f63b85f8a7b_26-Highlights%20from%20the%20EP%20roundtable%20event%20%E2%80%9CEnsuring%20Appropriate%20Patient%20Access%20to%20PDMPs.jpg

561 ms

647f043cb8b7a35d7b495a8e_Presentation%20of%20the%202020%20Joachim%20Hilfenhaus%20Award.webp

647f043cb8b7a35d7b495a8e_Presentation%20of%20the%202020%20Joachim%20Hilfenhaus%20Award.webp

357 ms

split-type@0.3.4

split-type@0.3.4

13 ms

index.min.js

index.min.js

15 ms

647f061a7a36fb101cd56238_-Presentation%20of%20the%202020%20RObert%20W.%20Award.webp

647f061a7a36fb101cd56238_-Presentation%20of%20the%202020%20RObert%20W.%20Award.webp

338 ms

647f03b4ed647d9b748403f8_Plasma-%20An%20Overview%201.webp

647f03b4ed647d9b748403f8_Plasma-%20An%20Overview%201.webp

338 ms

647f03c475a3469fe62047d4_Experts%20on%20Coronavirus-%20The%20Virus%2C%20The%20Disease%2C%20Prevention%20and%20Treatment.webp

647f03c475a3469fe62047d4_Experts%20on%20Coronavirus-%20The%20Virus%2C%20The%20Disease%2C%20Prevention%20and%20Treatment.webp

338 ms

647f03d27a36fb101cd39afd_Patient%20Perspectives%20on%20COVID-19%20and%20Access%20to%20Care.webp

647f03d27a36fb101cd39afd_Patient%20Perspectives%20on%20COVID-19%20and%20Access%20to%20Care.webp

336 ms

640b87b1a86b831745054d93_20-Combating%20COVID-19%20Industry%20Spotlight-%20Kedrion.jpg

640b87b1a86b831745054d93_20-Combating%20COVID-19%20Industry%20Spotlight-%20Kedrion.jpg

358 ms

647f04024d2ed85e434f8104_Keynote%20Address%20%E2%80%93%20Stella%20Kyriakides%2C%20European%20Commissioner%20for%20Health%20and%20Food%20Safety.webp

647f04024d2ed85e434f8104_Keynote%20Address%20%E2%80%93%20Stella%20Kyriakides%2C%20European%20Commissioner%20for%20Health%20and%20Food%20Safety.webp

357 ms

656fc9c703da3678e7350ac6_NunitoSans-VariableFont_YTLC%2Copsz%2Cwdth%2Cwght.ttf

656fc9c703da3678e7350ac6_NunitoSans-VariableFont_YTLC%2Copsz%2Cwdth%2Cwght.ttf

354 ms

647f041fc69acb7889712bec_Keynote%20Address%20%E2%80%93%20Admiral%20Brett%20Giroir%2C%20MD%2C%20U.S.webp

647f041fc69acb7889712bec_Keynote%20Address%20%E2%80%93%20Admiral%20Brett%20Giroir%2C%20MD%2C%20U.S.webp

340 ms

647f0351aeb24b07b7825fb3_Plasma%20101.webp

647f0351aeb24b07b7825fb3_Plasma%20101.webp

336 ms

647f03677167f474e1a3d288_Welcome%20to%20the%20Global%20Plasma%20Summit.webp

647f03677167f474e1a3d288_Welcome%20to%20the%20Global%20Plasma%20Summit.webp

338 ms

647f0392bb4628bf7e372dd1_Combating%20COVID-19%20Industry%20Spotlight-%20Kedrion.webp

647f0392bb4628bf7e372dd1_Combating%20COVID-19%20Industry%20Spotlight-%20Kedrion.webp

340 ms

640b870aab21ca640195670c_15-Combating%20COVID-19%20Industry%20Spotlight-%20Emergent.jpg

640b870aab21ca640195670c_15-Combating%20COVID-19%20Industry%20Spotlight-%20Emergent.jpg

338 ms

640b8730beb22e1683d3fba2_16-Combating%20COVID-19%20Industry%20Spotlight-%20Grifols.jpg

640b8730beb22e1683d3fba2_16-Combating%20COVID-19%20Industry%20Spotlight-%20Grifols.jpg

338 ms

647f034149330e40c32fd88e_Spotlight%20on%20Plasma%20Part%20One-%20Together%20We%20Are%20Stronger.webp

647f034149330e40c32fd88e_Spotlight%20on%20Plasma%20Part%20One-%20Together%20We%20Are%20Stronger.webp

314 ms

www-player.css

www-player.css

12 ms

www-embed-player.js

www-embed-player.js

111 ms

base.js

base.js

143 ms

647f0338dfba776327c0a5a8_-Highlights%20from%20the%20EP%20roundtable%20event%20%E2%80%9CEnsuring%20Appropriate%20Patient%20Access%20to%20PDMPs.webp

647f0338dfba776327c0a5a8_-Highlights%20from%20the%20EP%20roundtable%20event%20%E2%80%9CEnsuring%20Appropriate%20Patient%20Access%20to%20PDMPs.webp

312 ms

647f032ed97ffc4bb7dbaf5b_PPTA%20webinar%20on%20unique%20patient%20access%20challenges.webp

647f032ed97ffc4bb7dbaf5b_PPTA%20webinar%20on%20unique%20patient%20access%20challenges.webp

309 ms

647f0322ed647d9b74839c8d_Thank%20you%2C%20plasma%20donors.webp

647f0322ed647d9b74839c8d_Thank%20you%2C%20plasma%20donors.webp

310 ms

640b769117d12b8dfd713b42_From%20PPTA-%20Thank%20you%2C%20plasma%20donors!.jpg

640b769117d12b8dfd713b42_From%20PPTA-%20Thank%20you%2C%20plasma%20donors!.jpg

308 ms

640b763e65cb724954572a81_Prof.%20Lieven%20Annemans%20Speaks%20about%20the%20Value%20of%20Plasma-Derived%20Therapies.jpg

640b763e65cb724954572a81_Prof.%20Lieven%20Annemans%20Speaks%20about%20the%20Value%20of%20Plasma-Derived%20Therapies.jpg

279 ms

640b76303ecaf896122604cb_The%20Power%20of%20Plasma%20Donation%20Animation%20%5BHungarian%5D.jpg

640b76303ecaf896122604cb_The%20Power%20of%20Plasma%20Donation%20Animation%20%5BHungarian%5D.jpg

269 ms

640b7611ce1a574ce102b532_The%20Power%20of%20Plasma%20Donation%20%5BCzech%5D.jpg

640b7611ce1a574ce102b532_The%20Power%20of%20Plasma%20Donation%20%5BCzech%5D.jpg

206 ms

640b76249df6981e9585d07c_The%20Power%20of%20Plasma%20Donation%20%5BSpanish%5D.jpg

640b76249df6981e9585d07c_The%20Power%20of%20Plasma%20Donation%20%5BSpanish%5D.jpg

207 ms

640b75fdba675217d2dfdb27_The%20Power%20of%20Plasma%20Donation%20-%20Animation%20(German.jpg

640b75fdba675217d2dfdb27_The%20Power%20of%20Plasma%20Donation%20-%20Animation%20(German.jpg

184 ms

640b75d6d086fd0bf9a4c46e_The%20Power%20of%20Plasma%20Donation%20-%20Animation%20(English).jpg

640b75d6d086fd0bf9a4c46e_The%20Power%20of%20Plasma%20Donation%20-%20Animation%20(English).jpg

182 ms

6679abd4aad402f239ecd1d9_PPTA%20Welcomes%20EMA%20Regulatory%20Update%20on%20vCJD.png

6679abd4aad402f239ecd1d9_PPTA%20Welcomes%20EMA%20Regulatory%20Update%20on%20vCJD.png

182 ms

665636bf0d1b87aa18a45313_PPTA%20Welcomes%20Sharon%20Pearce%20as%20new%20Vice%20President%2C%20Lead%20of%20Government%20Affairs.png

665636bf0d1b87aa18a45313_PPTA%20Welcomes%20Sharon%20Pearce%20as%20new%20Vice%20President%2C%20Lead%20of%20Government%20Affairs.png

182 ms

6647d54515614ddc8c5722df_PPTA%20Regards%20SoHO%20Adoption.png

6647d54515614ddc8c5722df_PPTA%20Regards%20SoHO%20Adoption.png

376 ms

661e9c14ea2086205cee6d45_Frame%208.png

661e9c14ea2086205cee6d45_Frame%208.png

226 ms

65cb82e0627857250997f98a_PPTA%20Responds%20to%20SoHo%20Regulation%20Compromise.png

65cb82e0627857250997f98a_PPTA%20Responds%20to%20SoHo%20Regulation%20Compromise.png

224 ms

65b7dd5aa9b8b752fe10079f_PR_New%20Staff%20Members%20Aim%20to%20Further%20Plasma%20Sector%20Innovation%20and%20Advocacy.png

65b7dd5aa9b8b752fe10079f_PR_New%20Staff%20Members%20Aim%20to%20Further%20Plasma%20Sector%20Innovation%20and%20Advocacy.png

222 ms

65b7df07b61ae75ad27697fe_Summary%20of%20the%20PPTA-FDA%20Liaison%20Meeting%20_November%208%2C%202023.png

65b7df07b61ae75ad27697fe_Summary%20of%20the%20PPTA-FDA%20Liaison%20Meeting%20_November%208%2C%202023.png

222 ms

65809cf4822ca506285632da_PPTA%20Statement%20on%20Issuance%20of%20the%20EU%20Critical%20Medicines%20List.png

65809cf4822ca506285632da_PPTA%20Statement%20on%20Issuance%20of%20the%20EU%20Critical%20Medicines%20List.png

226 ms

6569eb28efdedfdab3f93078_Statement_Quebec%20Biovigilance%20Committee%E2%80%99s%208th%20Biovigilance%20Forum.png

6569eb28efdedfdab3f93078_Statement_Quebec%20Biovigilance%20Committee%E2%80%99s%208th%20Biovigilance%20Forum.png

242 ms

653bb594a6c34d5e72a60116_PPTA%20Statement%20on%20the%20Council%E2%80%99s%20negotiating%20mandate%20on%20the%20SoHO%20Regulation.png

653bb594a6c34d5e72a60116_PPTA%20Statement%20on%20the%20Council%E2%80%99s%20negotiating%20mandate%20on%20the%20SoHO%20Regulation.png

241 ms

65003d35372e2c6eb3ed1c3a_European%20Parliament%20Misses%20Opportunity_statement%20thumbnail.png

65003d35372e2c6eb3ed1c3a_European%20Parliament%20Misses%20Opportunity_statement%20thumbnail.png

239 ms

64e8db1fc4f9b5fe8a06936f_Press%20Release_Frequency%20of%20Source%20Plasma%20Donation.png

64e8db1fc4f9b5fe8a06936f_Press%20Release_Frequency%20of%20Source%20Plasma%20Donation.png

244 ms

64b6b69de16edaa03608ece9_eaafe274-bdda-49ab-a4e2-bcff82374574.jpg

64b6b69de16edaa03608ece9_eaafe274-bdda-49ab-a4e2-bcff82374574.jpg

236 ms

64b6b6a6209580eb39d4392d_54ace86c-b8d7-4d0d-a13a-4a332086d0a2.jpg

64b6b6a6209580eb39d4392d_54ace86c-b8d7-4d0d-a13a-4a332086d0a2.jpg

258 ms

638f8abf38dba3ab3d679127_HouschkaPro-Bold.ttf

638f8abf38dba3ab3d679127_HouschkaPro-Bold.ttf

175 ms

638f8ac0c53eeac078c5858e_HouschkaPro-DemiBold.ttf

638f8ac0c53eeac078c5858e_HouschkaPro-DemiBold.ttf

360 ms

63923fc9593c75e7278de3ed_HouschkaPro-Medium.ttf

63923fc9593c75e7278de3ed_HouschkaPro-Medium.ttf

364 ms

638f8abfcc8ca5b9dc73245f_HouschkaPro-Light.ttf

638f8abfcc8ca5b9dc73245f_HouschkaPro-Light.ttf

245 ms

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

41 ms

64513026d43f611f48463442_PPTA%20Statement%20on%20the%20Revision%20of%20the%20General%20EU%20Pharmaceutical%20Legislation.jpg

64513026d43f611f48463442_PPTA%20Statement%20on%20the%20Revision%20of%20the%20General%20EU%20Pharmaceutical%20Legislation.jpg

260 ms

ad_status.js

ad_status.js

212 ms

63f789a880a1c7578dd3ad10_Announcing%20PPTA%E2%80%99s%20New%20Global%20Chair.jpeg

63f789a880a1c7578dd3ad10_Announcing%20PPTA%E2%80%99s%20New%20Global%20Chair.jpeg

238 ms

647db4b96c6c83d632ca4465_Announcing%20PPTA%E2%80%99s%20New%20Global%20Chair-1.webp

647db4b96c6c83d632ca4465_Announcing%20PPTA%E2%80%99s%20New%20Global%20Chair-1.webp

349 ms

641232b7b72e62d53933925d_Monkeypox%20Virus%20and%20Plasma%20Protein%20Therapies.jpg

641232b7b72e62d53933925d_Monkeypox%20Virus%20and%20Plasma%20Protein%20Therapies.jpg

333 ms

647db49cb777092b85ad18ad_PPTA%20Executive%20Summary%20of%20FDA%E2%80%99s%20U.S.%20Immunoglobulin%20Utilization%20Study%20Report.webp

647db49cb777092b85ad18ad_PPTA%20Executive%20Summary%20of%20FDA%E2%80%99s%20U.S.%20Immunoglobulin%20Utilization%20Study%20Report.webp

333 ms

647db473cdf8acb90fcd8beb_PPTA%20Statement%20on%20Review%20of%20Donor%20Blood%20Pressure%20Requirements.webp

647db473cdf8acb90fcd8beb_PPTA%20Statement%20on%20Review%20of%20Donor%20Blood%20Pressure%20Requirements.webp

334 ms

647db47a9ea2c195552c49f4_PPTA%20Statement%20on%20Review%20of%20Donor%20Weight%20Loss%20Monitoring.webp

647db47a9ea2c195552c49f4_PPTA%20Statement%20on%20Review%20of%20Donor%20Weight%20Loss%20Monitoring.webp

333 ms

647db13f3dd33dcf680588c8_Statement%20on%20Update%20on%20Safety%20of%20Albumin.webp

647db13f3dd33dcf680588c8_Statement%20on%20Update%20on%20Safety%20of%20Albumin.webp

335 ms

647db12be1637b3d214fb67d_PPTA%20Statement%20on%20Safety%20of%20Plasma%20Protein%20Therapies%20and%20the%20H5N1%20Viruses.webp

647db12be1637b3d214fb67d_PPTA%20Statement%20on%20Safety%20of%20Plasma%20Protein%20Therapies%20and%20the%20H5N1%20Viruses.webp

332 ms

647db11ce1637b3d214fac2d_Statement%20on%20the%20Safety%20of%20Plasma%20Protein%20Therapies%20and%20Swine%20Influenza%20Virus.webp

647db11ce1637b3d214fac2d_Statement%20on%20the%20Safety%20of%20Plasma%20Protein%20Therapies%20and%20Swine%20Influenza%20Virus.webp

335 ms

647db10a6d00d515fbf8f37c_Human%20Parvovirus%20PARV4%20and%20plasma%20protein%20therapies.webp

647db10a6d00d515fbf8f37c_Human%20Parvovirus%20PARV4%20and%20plasma%20protein%20therapies.webp

332 ms

647db0fa547c982b6aac8957_Ebola%20Virus%20and%20Plasma%20Protein%20Therapies.webp

647db0fa547c982b6aac8957_Ebola%20Virus%20and%20Plasma%20Protein%20Therapies.webp

335 ms

647db0d3aa7268106a63d2c9_PPTA%20Statement%20on%20MSM%20Donor%20Policy.webp

647db0d3aa7268106a63d2c9_PPTA%20Statement%20on%20MSM%20Donor%20Policy.webp

335 ms

647db0b8102d54f8e72fd2c0_Zika%20Virus%20and%20Plasma%20Protein%20Therapies.webp

647db0b8102d54f8e72fd2c0_Zika%20Virus%20and%20Plasma%20Protein%20Therapies.webp

334 ms

647db0aa3dd33dcf6804e0c8_Plasma%20protein%20product%20safety%20and%20Creutzfeldt-Jakob%20disease%20(CJD).webp

647db0aa3dd33dcf6804e0c8_Plasma%20protein%20product%20safety%20and%20Creutzfeldt-Jakob%20disease%20(CJD).webp

336 ms

647dafe73fc86eb676dee159_PPTA%20Statement%20on%20%E2%80%9CHow%20Blood-Plasma%20Companies%20Target%20the%20Poorest%20Americans%E2%80%9D.webp

647dafe73fc86eb676dee159_PPTA%20Statement%20on%20%E2%80%9CHow%20Blood-Plasma%20Companies%20Target%20the%20Poorest%20Americans%E2%80%9D.webp

334 ms

647daf616a96b14dde48589f_New%20Coronavirus%20(SARS-CoV-2)%20and%20the%20Safety%20Margins%20of%20Plasma%20Protein%20Therapies.webp

647daf616a96b14dde48589f_New%20Coronavirus%20(SARS-CoV-2)%20and%20the%20Safety%20Margins%20of%20Plasma%20Protein%20Therapies.webp

334 ms

647daf31547c982b6aaa8a11_A%20Note%20to%20U.S.%20Plasma%20Donors%20on%20the%20Spread%20of%20Coronavirus.webp

647daf31547c982b6aaa8a11_A%20Note%20to%20U.S.%20Plasma%20Donors%20on%20the%20Spread%20of%20Coronavirus.webp

337 ms

647daf218b5396b1365cf4f6_PPTA%20Responds%20to%20The%20Guardian%20Article.webp

647daf218b5396b1365cf4f6_PPTA%20Responds%20to%20The%20Guardian%20Article.webp

334 ms

647daf083dd33dcf68034189_PPTA%20Statement%20on%20FDA%20Guidance%20Documents.webp

647daf083dd33dcf68034189_PPTA%20Statement%20on%20FDA%20Guidance%20Documents.webp

332 ms

647daee43457b0aaadeba93d_PPTA%20Repeats%20Appeals%20for%20Plasma%20Donations.webp

647daee43457b0aaadeba93d_PPTA%20Repeats%20Appeals%20for%20Plasma%20Donations.webp

333 ms

647daed2f932c383c002ca5e_New%20York%20and%20California%20recognize%20the%20importance%20of%20plasma%20donation.webp

647daed2f932c383c002ca5e_New%20York%20and%20California%20recognize%20the%20importance%20of%20plasma%20donation.webp

333 ms

6412373bde5b7ec7d0038f13_Plasma%20Donors%20Should%20be%20Celebrated%2C%20not%20Denigrated.jpg

6412373bde5b7ec7d0038f13_Plasma%20Donors%20Should%20be%20Celebrated%2C%20not%20Denigrated.jpg

334 ms

embed.js

embed.js

52 ms

KFOmCnqEu92Fr1Mu4mxP.ttf

KFOmCnqEu92Fr1Mu4mxP.ttf

49 ms

KFOlCnqEu92Fr1MmEU9fBBc9.ttf

KFOlCnqEu92Fr1MmEU9fBBc9.ttf

56 ms

647dae03bcf9b387d1ed8df5_PPTA%20Statement%20on%20the%20Urgent%20Need%20for%20Plasma%20Donation.webp

647dae03bcf9b387d1ed8df5_PPTA%20Statement%20on%20the%20Urgent%20Need%20for%20Plasma%20Donation.webp

173 ms

647dadee750e3bbfe5067958_PPTA%20Statement%20on%20Alberta%E2%80%99s%20Passing%20of%20the%20Voluntary%20Blood%20Donation%20Repeal%20Act.webp

647dadee750e3bbfe5067958_PPTA%20Statement%20on%20Alberta%E2%80%99s%20Passing%20of%20the%20Voluntary%20Blood%20Donation%20Repeal%20Act.webp

164 ms

647dadd1bcf9b387d1ed5b76_Yes%20you%20can%20donate%20source%20plasma%20after%20getting%20the%20COVID%20vaccine.webp

647dadd1bcf9b387d1ed5b76_Yes%20you%20can%20donate%20source%20plasma%20after%20getting%20the%20COVID%20vaccine.webp

161 ms

641235622d51fe6c137478da_PPTA%20Statement%20on%20Immunoglobulin%20Use%20to%20Meet%20Clinical%20Need.jpg

641235622d51fe6c137478da_PPTA%20Statement%20on%20Immunoglobulin%20Use%20to%20Meet%20Clinical%20Need.jpg

162 ms

6412353fe640042ced25d59b_Human%20Plasma%20Donations%20Remain%20Important%20During%20COVID-19%20Pandemic.jpg

6412353fe640042ced25d59b_Human%20Plasma%20Donations%20Remain%20Important%20During%20COVID-19%20Pandemic.jpg

162 ms

641234c4be6af3de9c05adfe_New%20position%20statement%20by%20CHMP.jpg

641234c4be6af3de9c05adfe_New%20position%20statement%20by%20CHMP.jpg

161 ms

Create

Create

36 ms

id

id

13 ms

64123480e3567dc2711f56e9_Study%20Shows%20Immunoglobulin%20Therapy%20is%20%E2%80%9CCritical%20and%20Cost-Effective%E2%80%9D%20in%20Treating%20CVID.jpg

64123480e3567dc2711f56e9_Study%20Shows%20Immunoglobulin%20Therapy%20is%20%E2%80%9CCritical%20and%20Cost-Effective%E2%80%9D%20in%20Treating%20CVID.jpg

146 ms

641234402ba5cd084da0abbe_PPTA%20Responds%20to%20ProPublica%20Article.jpg

641234402ba5cd084da0abbe_PPTA%20Responds%20to%20ProPublica%20Article.jpg

143 ms

64123427785ab51cc2322b37_Plasma%20donations%20remain%20disappointingly%20low%20through%20ongoing%20pandemic%2C%20risking%20patients%E2%80%99%20lives.jpg

64123427785ab51cc2322b37_Plasma%20donations%20remain%20disappointingly%20low%20through%20ongoing%20pandemic%2C%20risking%20patients%E2%80%99%20lives.jpg

146 ms

64123355f4797207b144d092_PPTA%20Disagrees%20with%20Ruling%20from%20Romanian%20Competition%20Council.jpg

64123355f4797207b144d092_PPTA%20Disagrees%20with%20Ruling%20from%20Romanian%20Competition%20Council.jpg

145 ms

641232f8e9d81a308a26a679_PPTA%20Leadership%20Update%20%E2%80%93%20Amy%20Efantis.jpg

641232f8e9d81a308a26a679_PPTA%20Leadership%20Update%20%E2%80%93%20Amy%20Efantis.jpg

139 ms

641232d1cf47f3373c340249_PPTA%20Statement%20on%20the%20Ukraine%20Crisis.jpg

641232d1cf47f3373c340249_PPTA%20Statement%20on%20the%20Ukraine%20Crisis.jpg

127 ms

641231aacf47f34c4333e279_PPTA%20Statement%20on%20Report%20of%20ENVI%20Rapporteur%20for%20the%20SoHO%20Regulation.jpg

641231aacf47f34c4333e279_PPTA%20Statement%20on%20Report%20of%20ENVI%20Rapporteur%20for%20the%20SoHO%20Regulation.jpg

125 ms

6412329c77776449cc17b914_PPTA%20Statement%20on%20the%20draft%20EU%20Substances%20of%20Human%20Origin%20Regulation.jpg

6412329c77776449cc17b914_PPTA%20Statement%20on%20the%20draft%20EU%20Substances%20of%20Human%20Origin%20Regulation.jpg

54 ms

641239acb5d14a80d8fbf232_PPTA%20Recognizes%20First%20Plasma%20Collection%20Centers%20Certified%20in%20Hungary.jpg

641239acb5d14a80d8fbf232_PPTA%20Recognizes%20First%20Plasma%20Collection%20Centers%20Certified%20in%20Hungary.jpg

53 ms

6412399ac851e8a51ffcf144_PPTA%20Recognizes%20World%20Hemophilia%20Day%202014.jpg

6412399ac851e8a51ffcf144_PPTA%20Recognizes%20World%20Hemophilia%20Day%202014.jpg

53 ms

6412396fc0dfaad0f5775013_International%20Plasma%20Awareness%20Week%20to%20Celebrate%20Donors%20and%20Spotlight%20Rare%20Diseases.jpg

6412396fc0dfaad0f5775013_International%20Plasma%20Awareness%20Week%20to%20Celebrate%20Donors%20and%20Spotlight%20Rare%20Diseases.jpg

53 ms

64123924c0dfaa7ef2774de4_Ensuring%20Access%20to%20Medicines%20for%20Patients.jpg

64123924c0dfaa7ef2774de4_Ensuring%20Access%20to%20Medicines%20for%20Patients.jpg

53 ms

64123902335faa2da1da6c78_PPTA%20Recognizes%208th%20Annual%20International%20Rare%20Disease%20Day.jpg

64123902335faa2da1da6c78_PPTA%20Recognizes%208th%20Annual%20International%20Rare%20Disease%20Day.jpg

53 ms

641238eb779503320cbfad82_PPTA%20Recognizes%20World%20Hemophilia%20Day%E2%80%93April%2017%2C%202015.jpg

641238eb779503320cbfad82_PPTA%20Recognizes%20World%20Hemophilia%20Day%E2%80%93April%2017%2C%202015.jpg

54 ms

641238bf2765fc5d219821c0_Alabama%20Lowers%20Minimum%20Donation%20Age%20to%2018.jpg

641238bf2765fc5d219821c0_Alabama%20Lowers%20Minimum%20Donation%20Age%20to%2018.jpg

53 ms

64123858f13e772391efd519_PPTA%20Recognizes%20Essential%20Contributions%20of%20Plasma%20Donors.jpg

64123858f13e772391efd519_PPTA%20Recognizes%20Essential%20Contributions%20of%20Plasma%20Donors.jpg

53 ms

6412383cb0e1a50baa40d882_PPTA%20Names%20Amy%20Efantis%20President%20%26%20CEO.jpg

6412383cb0e1a50baa40d882_PPTA%20Names%20Amy%20Efantis%20President%20%26%20CEO.jpg

52 ms

6412380c0762e5a621428314_Plasma-Derived%20Therapies%20Provide%20Significant%20Health%20Value%20Gain.jpg

6412380c0762e5a621428314_Plasma-Derived%20Therapies%20Provide%20Significant%20Health%20Value%20Gain.jpg

55 ms

641237ab970e0d02053c31f1_EU%20Health%20Commissioner%20Says%20Plasma%20Donation%20is%20%E2%80%9CMore%20Important%20Than%20Ever%E2%80%9D.jpg

641237ab970e0d02053c31f1_EU%20Health%20Commissioner%20Says%20Plasma%20Donation%20is%20%E2%80%9CMore%20Important%20Than%20Ever%E2%80%9D.jpg

51 ms

64123765c851e87934fcc784_International%20Plasma%20Awareness%20Week%202020_%20Be%20a%20Hero%2C%20Donate%20Plasma%20Today.jpg

64123765c851e87934fcc784_International%20Plasma%20Awareness%20Week%202020_%20Be%20a%20Hero%2C%20Donate%20Plasma%20Today.jpg

53 ms

641237110762e5240942793b_Inception%20Impact%20Assessment%20Underlines%20the%20Need%20for%20Timely%20Action.jpg

641237110762e5240942793b_Inception%20Impact%20Assessment%20Underlines%20the%20Need%20for%20Timely%20Action.jpg

53 ms

64123518e3567d81661f5b7e_Lifting%20of%20long-time%20ban%20on%20use%20of%20UK%20plasma.jpg

64123518e3567d81661f5b7e_Lifting%20of%20long-time%20ban%20on%20use%20of%20UK%20plasma.jpg

54 ms

6412345b9202ad0bd1033cfc_EU%20Health%20Commissioner%20says%20plasma%20donation%20plays%20a%20vital%20role.jpg

6412345b9202ad0bd1033cfc_EU%20Health%20Commissioner%20says%20plasma%20donation%20plays%20a%20vital%20role.jpg

52 ms

641233d4f4797202c344d618_International%20Plasma%20Awareness%20Week%202021_%20Donate%20Plasma.%20Save%20Lives..jpg

641233d4f4797202c344d618_International%20Plasma%20Awareness%20Week%202021_%20Donate%20Plasma.%20Save%20Lives..jpg

84 ms

641233a0cf47f35f9b3416b1_Calling%20on%20EU%20Policymakers%20to%20Increase%20Plasma%20Donations.jpg

641233a0cf47f35f9b3416b1_Calling%20on%20EU%20Policymakers%20to%20Increase%20Plasma%20Donations.jpg

51 ms

6412338425c8c1512e37511e_Adoption%20of%20the%20EP%20report%20%E2%80%9CEU%20Pharmaceutical%20Strategy%E2%80%9D.jpg

6412338425c8c1512e37511e_Adoption%20of%20the%20EP%20report%20%E2%80%9CEU%20Pharmaceutical%20Strategy%E2%80%9D.jpg

52 ms

6412336e7e9c7f47f4aade2b_A%20missed%20opportunity%20to%20acknowledge%20EU%E2%80%99s%20dependency%20on%20U.S.%20plasma.jpg

6412336e7e9c7f47f4aade2b_A%20missed%20opportunity%20to%20acknowledge%20EU%E2%80%99s%20dependency%20on%20U.S.%20plasma.jpg

54 ms

6412328036c393b16ffff225_International%20Plasma%20Awareness%20Week%202022_%20Donate%20Locally.%20Think%20Globally..jpg

6412328036c393b16ffff225_International%20Plasma%20Awareness%20Week%202022_%20Donate%20Locally.%20Think%20Globally..jpg

53 ms

6412132d2b84678043e4e631_podcast-ep6.webp

6412132d2b84678043e4e631_podcast-ep6.webp

52 ms

64121337f702ee464cf074f2_podcast-ep5.webp

64121337f702ee464cf074f2_podcast-ep5.webp

52 ms

64121340504eb80742485126_podcast-ep4.webp

64121340504eb80742485126_podcast-ep4.webp

236 ms

6412134a3c6111a1f016670d_podcast-ep2.webp

6412134a3c6111a1f016670d_podcast-ep2.webp

95 ms

663b9905603604c770c489d0_Cover_PPTA%20The%20Source%20Spring%202024_FINAL_v2.png

663b9905603604c770c489d0_Cover_PPTA%20The%20Source%20Spring%202024_FINAL_v2.png

66 ms

65844dc5da6098a5986c2c1f_The%20Source%20Winter%202023_Cover.png

65844dc5da6098a5986c2c1f_The%20Source%20Winter%202023_Cover.png

87 ms

6512dbe219591af9676f5e85_Cover_The%20Source%20Fall%202023_FINAL_.png

6512dbe219591af9676f5e85_Cover_The%20Source%20Fall%202023_FINAL_.png

207 ms

647e086b9e879f393a89106c_Spring%202023.webp

647e086b9e879f393a89106c_Spring%202023.webp

91 ms

63ffd23364815ab5b73d4554_Winter2022.png

63ffd23364815ab5b73d4554_Winter2022.png

87 ms

641f1471dd850a43cf783b8f_fall2022.webp

641f1471dd850a43cf783b8f_fall2022.webp

91 ms

647e08bbcf55e2b1c526b506_Spring2022.webp

647e08bbcf55e2b1c526b506_Spring2022.webp

95 ms

647dee03e46ea344f0947800_Fall2021.webp

647dee03e46ea344f0947800_Fall2021.webp

94 ms

647e089ee205524429f0bd37_Spring2021.webp

647e089ee205524429f0bd37_Spring2021.webp

96 ms

647e09764e0e28315fb85cd8_Winter2020.webp

647e09764e0e28315fb85cd8_Winter2020.webp

100 ms

647e083641b4323a54496983_Fall2020.webp

647e083641b4323a54496983_Fall2020.webp

93 ms

647dedaf74fe97b9771769b9_Summer2020.webp

647dedaf74fe97b9771769b9_Summer2020.webp

80 ms

641f14bce5406c853eac72a7_spring2020.webp

641f14bce5406c853eac72a7_spring2020.webp

82 ms

647dcae057f12027a86720c6_Winter2019.webp

647dcae057f12027a86720c6_Winter2019.webp

87 ms

647dcaab57f12027a866cd48_Fall2019.webp

647dcaab57f12027a866cd48_Fall2019.webp

93 ms

647dfaf662bc558e18243fc5_Summer2019.webp

647dfaf662bc558e18243fc5_Summer2019.webp

89 ms

641f14ac0bbd0a0af3f77586_spring2019.webp

641f14ac0bbd0a0af3f77586_spring2019.webp

90 ms

641f152c927bd577310cdf6c_winter2018.webp

641f152c927bd577310cdf6c_winter2018.webp

97 ms

641f146267c6995c2be28f76_fall2018.webp

641f146267c6995c2be28f76_fall2018.webp

107 ms

641f1501a2bd1e5e7f351699_summer2018.webp

641f1501a2bd1e5e7f351699_summer2018.webp

102 ms

63ffce006630b4d5977fd272_Spring2018.png

63ffce006630b4d5977fd272_Spring2018.png

110 ms

GenerateIT

GenerateIT

28 ms

63ffce0de44be8f90a4e5802_Winter2017.png

63ffce0de44be8f90a4e5802_Winter2017.png

247 ms

647dc9ffe46ea344f06f5f48_Fall2017.webp

647dc9ffe46ea344f06f5f48_Fall2017.webp

112 ms

63ffce28ab5226ff704d4f7d_Summer2017.png

63ffce28ab5226ff704d4f7d_Summer2017.png

116 ms

641f149cb0bfffe36ce675c5_spring2017.webp

641f149cb0bfffe36ce675c5_spring2017.webp

119 ms

647dc9bce62f9df8c16450cc_Winter2016.webp

647dc9bce62f9df8c16450cc_Winter2016.webp

122 ms

647dc9a16f6677ae8ceb9ee3_Fall2016.webp

647dc9a16f6677ae8ceb9ee3_Fall2016.webp

125 ms

641f14f3697d56cb88285de5_summer2016.webp

641f14f3697d56cb88285de5_summer2016.webp

129 ms

63ffce6b101f3cb8e7163fb1_Spring2016.png

63ffce6b101f3cb8e7163fb1_Spring2016.png

133 ms

641f151e82c9bbd0f13ec68e_winter2015.webp

641f151e82c9bbd0f13ec68e_winter2015.webp

150 ms

641f1454927bd5279f0cce26_fall2015.webp

641f1454927bd5279f0cce26_fall2015.webp

140 ms

63ffce9d774b8238628ba6f3_Summer2015.png

63ffce9d774b8238628ba6f3_Summer2015.png

146 ms

647dc3a03713086ebdd5687d_Spring2015.webp

647dc3a03713086ebdd5687d_Spring2015.webp

154 ms

63ffcf04581201c0b76ce2a2_Winter2014.png

63ffcf04581201c0b76ce2a2_Winter2014.png

138 ms

641f1443a2bd1eb79e350d6a_fall2014.webp

641f1443a2bd1eb79e350d6a_fall2014.webp

135 ms

647dc35111e8fde08e0cb167_Summer2014.webp

647dc35111e8fde08e0cb167_Summer2014.webp

128 ms

63ffcf36e0df4705d2d4f5e1_Spring2014.png

63ffcf36e0df4705d2d4f5e1_Spring2014.png

129 ms

647dc32b08d3c86a545134c2_Winter2013.webp

647dc32b08d3c86a545134c2_Winter2013.webp

135 ms

647dc3134ace8ece2dacb72a_Fall2013.webp

647dc3134ace8ece2dacb72a_Fall2013.webp

132 ms

647dc2fb6c6c83d632d8a35e_Summer2013.webp

647dc2fb6c6c83d632d8a35e_Summer2013.webp

142 ms

647dc2edb46dbdbe9a8e3de0_Spring2013.webp

647dc2edb46dbdbe9a8e3de0_Spring2013.webp

134 ms

647dbe060e044a9ddaccf25c_Winter2012.webp

647dbe060e044a9ddaccf25c_Winter2012.webp

142 ms

647dbdf506246eacecec758c_Fall2012.webp

647dbdf506246eacecec758c_Fall2012.webp

138 ms

647dbd79b777092b85b5a649_Summer2012.webp

647dbd79b777092b85b5a649_Summer2012.webp

139 ms

647dbd666f6677ae8cdf8581_Spring2012.webp

647dbd666f6677ae8cdf8581_Spring2012.webp

139 ms

647dbd4d0764a3c41012c49c_Winter2011.webp

647dbd4d0764a3c41012c49c_Winter2011.webp

137 ms

647dbd30e46ea344f0627bdd_Fall%202011.webp

647dbd30e46ea344f0627bdd_Fall%202011.webp

142 ms

647dbd1d155d0a94f97df150_Summer2011.webp

647dbd1d155d0a94f97df150_Summer2011.webp

136 ms

647dbd11cdf8acb90fd6a883_Spring2011.webp

647dbd11cdf8acb90fd6a883_Spring2011.webp

136 ms

668e946b1b815963833e50be_Plasma%20Protein%20Therapeutics%20Association.png

668e946b1b815963833e50be_Plasma%20Protein%20Therapeutics%20Association.png

139 ms

668e91ce83b3b47506212b62_A%20Mid-Year%20Message%20from%20PPTA%20President%20and%20CEO%20Anita%20Brikman.png

668e91ce83b3b47506212b62_A%20Mid-Year%20Message%20from%20PPTA%20President%20and%20CEO%20Anita%20Brikman.png

136 ms

665733c5d087a38247c8c37b_NAME%20TAGS.png

665733c5d087a38247c8c37b_NAME%20TAGS.png

137 ms

6601a00da69e028bc570cec7_Option%202.png

6601a00da69e028bc570cec7_Option%202.png

279 ms

66019f4ad564d4d03ce48025_Option%201.png

66019f4ad564d4d03ce48025_Option%201.png

130 ms

65d4d1ae4770d72dd7926027_Blog_PPTA%20Unveils%20Program%20for%20IPPC%202024.png

65d4d1ae4770d72dd7926027_Blog_PPTA%20Unveils%20Program%20for%20IPPC%202024.png

129 ms

65425a265e9b84eb846165da_Screenshot%202023-09-28%20at%206.50.20%20PM.png

65425a265e9b84eb846165da_Screenshot%202023-09-28%20at%206.50.20%20PM.png

129 ms

6541456c0eff5192f5c3ef24_Blog%20post_A%20Story%20of%20Alpha-1%20Antitrypsin%20Deficiency.png

6541456c0eff5192f5c3ef24_Blog%20post_A%20Story%20of%20Alpha-1%20Antitrypsin%20Deficiency.png

130 ms

64de6f5e8771fad0bd4f9861_Blog%20post%20title.png

64de6f5e8771fad0bd4f9861_Blog%20post%20title.png

132 ms

64cabf656ecc2932d84b132c_BLog%20post.png

64cabf656ecc2932d84b132c_BLog%20post.png

129 ms

64d6220115ceb63434d408a4_Takeda.png

64d6220115ceb63434d408a4_Takeda.png

123 ms

64d6220115ceb63434d408a5_Kedrion.png

64d6220115ceb63434d408a5_Kedrion.png

125 ms

64d6220115ceb63434d408a6_Grifols.png

64d6220115ceb63434d408a6_Grifols.png

124 ms

64d6220115ceb63434d408ab_Adma%20biocenters.png

64d6220115ceb63434d408ab_Adma%20biocenters.png

119 ms

64d6220115ceb63434d408b3_Kamada%20LTD..png

64d6220115ceb63434d408b3_Kamada%20LTD..png

115 ms

640f5e17276540830943e45c_1-ABOPlasma.svg

640f5e17276540830943e45c_1-ABOPlasma.svg

107 ms

640f5e209ca99431e6c2df55_4-Biolife.svg

640f5e209ca99431e6c2df55_4-Biolife.svg

109 ms

640f5ca1fcfd40ac829d1e02_36-Previpharma.svg

640f5ca1fcfd40ac829d1e02_36-Previpharma.svg

109 ms

640f5e3d958b5a07f9fd6a1e_21-UnicaPlasma.svg

640f5e3d958b5a07f9fd6a1e_21-UnicaPlasma.svg

118 ms

640f5eaad5f9213dff54c46f_Takeda.svg

640f5eaad5f9213dff54c46f_Takeda.svg

108 ms

640f5eb6abb73453b648e518_KedrionSpa.svg

640f5eb6abb73453b648e518_KedrionSpa.svg

110 ms

640f5e2167475356a8402960_5-BiomatUSAGrifols.svg

640f5e2167475356a8402960_5-BiomatUSAGrifols.svg

116 ms

640f5e1d7d9b4fd930093d17_2-AdmaBiocenter.svg

640f5e1d7d9b4fd930093d17_2-AdmaBiocenter.svg

112 ms

640f5e2c96f98f98c31acd77_13-KamadaPlasma.svg

640f5e2c96f98f98c31acd77_13-KamadaPlasma.svg

113 ms

640f5822640bb035abe1e3d4_Prothya.svg

640f5822640bb035abe1e3d4_Prothya.svg

111 ms

6420990cf2602a32a8f07088_Ellipse%20322.svg

6420990cf2602a32a8f07088_Ellipse%20322.svg

114 ms

6422f678d095d05ecaa4b98f_loading-gif.gif

6422f678d095d05ecaa4b98f_loading-gif.gif

110 ms

Accessibility Review

pptaglobal.org accessibility score

97

Accessibility Issues

Navigation

These are opportunities to improve keyboard navigation in your application.

Impact

Issue

High

Heading elements are not in a sequentially-descending order

Internationalization and localization

These are opportunities to improve the interpretation of your content by users in different locales.

Impact

Issue

High

<html> element does not have a [lang] attribute

Best Practices

pptaglobal.org best practices score

83

Areas of Improvement

Trust and Safety

Impact

Issue

High

Does not use HTTPS

Low

Ensure CSP is effective against XSS attacks

General

Impact

Issue

Low

Detected JavaScript libraries

High

Browser errors were logged to the console

High

Missing source maps for large first-party JavaScript

SEO Factors

pptaglobal.org SEO score

90

Search Engine Optimization Advices

Content Best Practices

Format your HTML in a way that enables crawlers to better understand your app’s content.

Impact

Issue

High

Links do not have descriptive text

Mobile Friendly

Make sure your pages are mobile friendly so users don’t have to pinch or zoom in order to read the content pages. [Learn more](https://developers.google.com/search/mobile-sites/).

Impact

Issue

High

Document uses legible font sizes

High

Tap targets are not sized appropriately

Language and Encoding

  • Language Detected

    EN

  • Language Claimed

    N/A

  • Encoding

    UTF-8

Language claimed in HTML meta tag should match the language actually used on the web page. Otherwise Pptaglobal.org can be misinterpreted by Google and other search engines. Our service has detected that English is used on the page, and neither this language nor any other was claimed in <html> or <meta> tags. Our system also found out that Pptaglobal.org main page’s claimed encoding is utf-8. Use of this encoding format is the best practice as the main page visitors from all over the world won’t have any issues with symbol transcription.

Social Sharing Optimization

pptaglobal.org

Open Graph data is detected on the main page of Pptaglobal. This is the best way to make the web page social media friendly. Here is how it looks like on Facebook: